Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biomaterials

Synthetic silk firm raises $35 million

by Alex Scott
May 15, 2021 | A version of this story appeared in Volume 99, Issue 18

 

A photo of synthetic silk fiber being spun.
Credit: AMSilk
AMSilk says its fibers are fully biodegradable under aerobic and marine conditions.

AMSilk, a German start-up making synthetic silk protein via bacterial fermentation, has raised $35 million in a series C investment round led by Novo Holdings, a major shareholder in Novo Nordisk and Novozymes. Other investors include Cargill. AMSilk’s protein is used in applications such as fibers to make sportswear. The firm will use the money to expand its manufacturing base and increase international sales. This is Novo Holdings’ 12th investment in a bioindustrial company.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.